GLAUcoma Diagnostic and Imaging Analysis (GLAUDIA) Study
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-90
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
About this trial
This observational study aims to identify early diagnostic markers of glaucomatous damage by combining functional and structural assessments. Patients with primary open-angle glaucoma and ocular hypertension will undergo comprehensive ophthalmological evaluation, including visual field testing and multimodal imaging of the optic nerve and retina. Both retrospective and prospective data will be collected. The main objective is to define new diagnostic paradigms for detecting early glaucomatous changes and to improve the accuracy of current clinical practice in glaucoma management.
Eligibility criteria
Qualifiers
Age between 40 and 90 years.
Best-corrected visual acuity ≥ 0.1 LogMAR (≥ 8/10).
IOP ≥ 21 mmHg with normal visual field and/or normal optic nerve head/RNFL, or
Suspicious optic nerve head (excavation), or
Disqualifiers
Best-corrected visual acuity worse than 0.1 LogMAR (< 8/10).
Ocular surgery in the last 6 months (except uncomplicated cataract extraction).
Previous vitreoretinal surgery for macular pathologies (e.g., macular pucker, macular hole) or retinal detachment.
High myopia (> -3 diopters).
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov